ZURICH, June 28 (Reuters) - Roche 's new multiple
sclerosis (MS) drug could be approved in the United States this
year, earlier than previously forecast, the Swiss drugmaker said
on Tuesday, after winning the U.S. regulator's priority review
status for the medicine.
Read more
No comments:
Post a Comment